Part of Huadong Medicine Co., Ltd., Sinclair Pharmaceuticals Ltd. is a company headquartered in Chester, UK, that manufactures and distributes pharmaceutical products. The firm was founded in 1971.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Alcyomics offers human in vitro (lab-based) pre-clinical safety testing to ensure drug safety and efficacy before first administration into man. They offer a consultancy service of how the pre-clinical data can be used to assist clinical trial development such as dose response and a stratified medicine approach to patient selection. Their technology is also a suitable alternative to animal testing for the cosmetics industry. In addition They offer immunogenicity and potency testing of novel chemicals. Alcyomics was founded in 2007 and started trading in 2009, providing technology support to the biotechnology, pharmaceutical and cosmetic industries, building on 30 years' research experience with the use of skin explant assays for predicting graft versus host disease and understanding its immunobiology.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Hydromer, Inc. is a polymer research and development company. It focuses on biotechnology and engages in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based products and services. The company serves in the medical device, pharmaceutical, animal health, biotechnology, industrial plastics, cosmetic and personal care markets. It operates through two business segments: Polymer Research and Medical Products. The Polymer Research segment products include Aquamere, Aquatrix, Dermaseal, Dragonhyde, Hydromer Anti-Fog/Condensation Control Coatings, Hydromer Lubricious Coatings, Sea-Slide and T-HEXX Barrier Dips and Sprays. The Medical Products segment provides biofeedback medical devices, contract coating services and engineering equipment sales and services. The company was founded by Manfred F. Dyck in 1980 and is headquartered in Concord, NC.

HDS, Inc. operates as a truck driving school. The firm has consulting division and a commercial vehicle maintenance and repair shop. the company is headquartered in Tucson, AZ.

The project is a biotech start-up, which has developed and tested an innovative technology for the treatment of skin with symptoms of psoriasis. The active ingredient of the cream is a herb. The initial development was directed for dermocosmetics application with a possibility to upgrade the substance to a herbal drug (after additional R&D work). The cream can also be used in diseases such as atopic dermatitis and contact dermatitis.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Part of Alliance Pharma Plc, Maelor Laboratories Ltd. is a company headquartered in Chippenham, UK. The firm engages in selling and marketing of pharmaceutical products & medical devices. It was founded in 1997.

Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.

BASF Beauty Care Solutions France SAS, a subsidiary of BASF SE, is a company headquartered in Lyon, France. The firm operates as a chemical company. It was founded in 1985. Patrick Ledjam is the CEO, in this role since 2013.

Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2018, the company has one approved drug (see the Products section below).